Controlling Bone Disease Improves Survival Of Hemodialysis Patients
Jul 4th 2008Drug InformationUrology
Consistently maintaining certain blood levels of markers of bone metabolism and disease can prolong the lives of patients on hemodialysis, according to a study appearing in the September 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that keeping parathyroid hormone, calcium, and phosphorous levels in control is critically important for dialysis patients with chronic kidney disease (CKD).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
